Wu Du

2.5k total citations
37 papers, 1.9k citations indexed

About

Wu Du is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Wu Du has authored 37 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 16 papers in Organic Chemistry and 9 papers in Oncology. Recurrent topics in Wu Du's work include Cancer therapeutics and mechanisms (11 papers), Catalytic C–H Functionalization Methods (6 papers) and Protein Degradation and Inhibitors (6 papers). Wu Du is often cited by papers focused on Cancer therapeutics and mechanisms (11 papers), Catalytic C–H Functionalization Methods (6 papers) and Protein Degradation and Inhibitors (6 papers). Wu Du collaborates with scholars based in United States, China and Japan. Wu Du's co-authors include Dennis P. Curran, Dale L. Boger, Inkyu Hwang, Benjamin F. Cravatt, Donmienne Leung, Christophe Hardouin, Heng Cheng, Motomu Kanai, Masakatsu Shibasaki and Kazuo Yabu and has published in prestigious journals such as Journal of the American Chemical Society, Nature Medicine and Cancer Research.

In The Last Decade

Wu Du

35 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wu Du United States 19 957 786 448 330 175 37 1.9k
Loredana Vesci Italy 30 1.1k 1.2× 558 0.7× 563 1.3× 144 0.4× 122 0.7× 73 2.0k
Jennifer J. Bouska United States 23 1.1k 1.1× 851 1.1× 643 1.4× 213 0.6× 50 0.3× 41 2.1k
Martin Rowlands United Kingdom 29 1.5k 1.6× 637 0.8× 273 0.6× 148 0.4× 99 0.6× 67 2.6k
H. D. Hollis Showalter United States 26 1.1k 1.2× 1.4k 1.8× 718 1.6× 170 0.5× 110 0.6× 64 2.5k
Akira Asai Japan 33 1.8k 1.8× 938 1.2× 649 1.4× 236 0.7× 195 1.1× 132 3.0k
Amarnath Natarajan United States 28 1.6k 1.7× 748 1.0× 585 1.3× 94 0.3× 75 0.4× 99 2.8k
S. David Kimball United States 25 802 0.8× 1.7k 2.1× 439 1.0× 220 0.7× 44 0.3× 50 2.6k
Hubert Josien United States 20 743 0.8× 704 0.9× 208 0.5× 255 0.8× 94 0.5× 34 1.6k
Jinyun Dong China 24 1.1k 1.1× 479 0.6× 733 1.6× 108 0.3× 132 0.8× 65 2.1k
Siavosh Mahboobi Germany 26 1.0k 1.1× 858 1.1× 369 0.8× 113 0.3× 83 0.5× 76 1.8k

Countries citing papers authored by Wu Du

Since Specialization
Citations

This map shows the geographic impact of Wu Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wu Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wu Du more than expected).

Fields of papers citing papers by Wu Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wu Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wu Du. The network helps show where Wu Du may publish in the future.

Co-authorship network of co-authors of Wu Du

This figure shows the co-authorship network connecting the top 25 collaborators of Wu Du. A scholar is included among the top collaborators of Wu Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wu Du. Wu Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morrill, Christie, Westley J. Friesen, Suresh Babu, et al.. (2022). Guanidino quinazolines and pyrimidines promote readthrough of premature termination codons in cells with native nonsense mutations. Bioorganic & Medicinal Chemistry Letters. 76. 128989–128989. 4 indexed citations
2.
Cao, Chao-Guo, Jie Yang, Yong Chen, et al.. (2020). Discovery of SK-575 as a Highly Potent and Efficacious Proteolysis-Targeting Chimera Degrader of PARP1 for Treating Cancers. Journal of Medicinal Chemistry. 63(19). 11012–11033. 65 indexed citations
3.
Du, Wu, et al.. (2020). Metabolically stable diphenylamine derivatives suppress androgen receptor and BET protein in prostate cancer. Biochemical Pharmacology. 177. 113946–113946. 10 indexed citations
4.
Chen, Luyu, Chao-Guo Cao, Lifeng Zhao, et al.. (2019). Development of selective mono or dual PROTAC degrader probe of CDK isoforms. European Journal of Medicinal Chemistry. 187. 111952–111952. 85 indexed citations
5.
Kreso, Antonija, Peter van Galen, Nicholas Pedley, et al.. (2013). Self-renewal as a therapeutic target in human colorectal cancer. Nature Medicine. 20(1). 29–36. 378 indexed citations
6.
Moon, Young‐Choon, Ramil Baiazitov, Wu Du, et al.. (2013). Chemoselective Reactions of 4,6-Dichloro-2-(methylsulfonyl)pyrimidine and Related Electrophiles with Amines. Synthesis. 45(13). 1764–1784. 17 indexed citations
7.
Liu, Zhaohua, Li Hou, Yuanyuan Li, et al.. (2012). Complement activation associated with polysorbate 80 in beagle dogs. International Immunopharmacology. 15(1). 144–149. 50 indexed citations
8.
Du, Wu, James P. Jewell, Linus S. Lin, et al.. (2009). Synthesis and evaluation of N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-aminopropanamide as human cannabinoid-1 receptor (CB1R) inverse agonists. Bioorganic & Medicinal Chemistry Letters. 19(17). 5195–5199. 7 indexed citations
9.
Romero, F. Anthony, Wu Du, Inkyu Hwang, et al.. (2007). Potent and Selective α-Ketoheterocycle-Based Inhibitors of the Anandamide and Oleamide Catabolizing Enzyme, Fatty Acid Amide Hydrolase. Journal of Medicinal Chemistry. 50(5). 1058–1068. 67 indexed citations
10.
Du, Wu, Quang Truong, Hongbo Qi, et al.. (2007). A one-pot synthesis of 3-substituted-5-carbonylmethyl-1,2,4-oxadiazoles from β-keto esters and amidoximes under solvent-free conditions. Tetrahedron Letters. 48(13). 2231–2235. 18 indexed citations
11.
Leung, Donmienne, Wu Du, Christophe Hardouin, et al.. (2005). Discovery of an exceptionally potent and selective class of fatty acid amide hydrolase inhibitors enlisting proteome-wide selectivity screening: concurrent optimization of enzyme inhibitor potency and selectivity. Bioorganic & Medicinal Chemistry Letters. 15(5). 1423–1428. 93 indexed citations
12.
Laco, Gary S., Wu Du, Glenda Kohlhagen, et al.. (2004). Analysis of human topoisomerase I inhibition and interaction with the cleavage site +1 deoxyguanosine, via in vitro experiments and molecular modeling studies. Bioorganic & Medicinal Chemistry. 12(19). 5225–5235. 17 indexed citations
13.
Du, Wu, Christophe Hardouin, Heng Cheng, Inkyu Hwang, & Dale L. Boger. (2004). Heterocyclic sulfoxide and sulfone inhibitors of fatty acid amide hydrolase. Bioorganic & Medicinal Chemistry Letters. 15(1). 103–106. 28 indexed citations
14.
Du, Wu. (2003). Semisynthesis of DB-67 and other silatecans from camptothecin by thiol-promoted addition of silyl radicals. Bioorganic & Medicinal Chemistry. 11(3). 451–458. 36 indexed citations
15.
Du, Wu, et al.. (2002). Synthesis and evaluation of a novel E-ring modified α-hydroxy keto ether analogue of camptothecin. Bioorganic & Medicinal Chemistry. 10(1). 103–110. 24 indexed citations
16.
Gabarda, Ana E., et al.. (2002). Asymmetric total synthesis of (20R)-homocamptothecin, substituted homocamptothecins and homosilatecans. Tetrahedron. 58(32). 6329–6341. 29 indexed citations
17.
Liu, Xinli, Bert C. Lynn, Jun Zhang, et al.. (2002). A Versatile Prodrug Approach for Liposomal Core-Loading of Water-Insoluble Camptothecin Anticancer Drugs. Journal of the American Chemical Society. 124(26). 7650–7651. 40 indexed citations
18.
Curran, Dennis P., Hubert Josien, David Bom, Ana E. Gabarda, & Wu Du. (2000). The Cascade Radical Annulation Approach to New Analogues of Camptothecins: Combinatorial Synthesis of Silatecans and Homosilatecans. Annals of the New York Academy of Sciences. 922(1). 112–121. 17 indexed citations
19.
Du, Wu, Ana E. Gabarda, David Bom, & Dennis P. Curran. (2000). The Combinatorial Synthesis of Racemic Homosilatecan Libraries via a Cascade Radical Annulation. Annals of the New York Academy of Sciences. 922(1). 317–319. 1 indexed citations
20.
Bom, David, Dennis P. Curran, Stefan Kruszewski, et al.. (2000). The Novel Silatecan 7-tert-Butyldimethylsilyl-10-hydroxycamptothecin Displays High Lipophilicity, Improved Human Blood Stability, and Potent Anticancer Activity. Journal of Medicinal Chemistry. 43(21). 3970–3980. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Loredana Vesci Breakdown of academic impact, for papers by Jennifer J. Bouska Breakdown of academic impact, for papers by Martin Rowlands Breakdown of academic impact, for papers by H. D. Hollis Showalter Breakdown of academic impact, for papers by Akira Asai Breakdown of academic impact, for papers by Amarnath Natarajan Breakdown of academic impact, for papers by S. David Kimball Breakdown of academic impact, for papers by Hubert Josien Breakdown of academic impact, for papers by Jinyun Dong Breakdown of academic impact, for papers by Siavosh Mahboobi
Rankless by CCL
2026